Trials / Completed
CompletedNCT07422428
Overlooked Barrier To Discontinuing Bont-A Therapy
Is The Insuffıcıent Patıent Informatıon An Overlooked Barrıer To Dıscontınuıng Bont-A Therapy For Post-Stroke Spastıcıty? A Retrospectıve Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- Suleyman Demirel University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate patient adherence to botulinum toxin (BoNT-A) treatment and identify the factors contributing to its discontinuation. This retrospective cohort study analyzed the medical records of patients who received at least one botulinum toxin treatment for post-stroke spasticity (PSS) from 2012 to 2024. Eighty-one enrolled patients responded to structured questions about their reasons for not consistently continuing BoNT-A treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | provide information by phone | Previous studies did not question why patients thought they did not benefit from the injection. For example, the expectations of patients who said they did not benefit were excessive. |
Timeline
- Start date
- 2024-09-23
- Primary completion
- 2025-02-10
- Completion
- 2025-04-05
- First posted
- 2026-02-20
- Last updated
- 2026-02-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07422428. Inclusion in this directory is not an endorsement.